Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000567632

Apexbio Technology LLC DIHYDROTANSHINONE-I-20MG
SDP

Catalog No. 5000567632
Encompass_Preferred

Dihydrotanshinone I (CAS No 87205-99-0) is a bioactive compound derived from the roots of Salvia miltiorrhiza commonly used in traditional Chinese medicine It belongs to the research category of natural product-based therapeutics with potential anticancer and anti-inflammatory activities The compound exerts its effects primarily through the inhibition of multiple signaling pathways including the NF- B and STAT3 pathways which are critical in cell proliferation and survival In vitro studies have shown that Dihydrotanshinone I possesses activity in the nanomolar to low micromolar range indicating strong potency It is extensively utilized in various cell models and animal studies to investigate its therapeutic potential and mechanism of action particularly in the context of drug screening for cancer treatment Experimental concentrations typically depend on the specific research design with careful adjustment to match the intended biological outcomes

Catalog No. 50-005-67632 Supplier Apexbio Technology LLC Supplier No. N184420
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Dihydrotanshinone I (CAS No 87205-99-0) is a bioactive compound derived from the roots of Salvia miltiorrhiza commonly used in traditional Chinese medicine It belongs to the research category of natural product-based therapeutics with potential anticancer and anti-inflammatory activities The compound exerts its effects primarily through the inhibition of multiple signaling pathways including the NF- B and STAT3 pathways which are critical in cell proliferation and survival In vitro studies have shown that Dihydrotanshinone I possesses activity in the nanomolar to low micromolar range indicating strong potency It is extensively utilized in various cell models and animal studies to investigate its therapeutic potential and mechanism of action particularly in the context of drug screening for cancer treatment Experimental concentrations typically depend on the specific research design with careful adjustment to match the intended biological outcomes

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.